Will Servier’s Massive Edgewise Acquisition Pay Off in the Rare Disease Market?
A major strategic transaction has emerged in the global pharmaceutical and biotechnology industry. French pharmaceutical company Servier has…
Amgen Expands US Biologics Manufacturing with $650 Million Investment
United States: Amgen (NASDAQ: AMGN) has announced a $650 million investment to expand its biologics manufacturing facilities in…


































































